📢 #medtwitter #nephtwitter

Part 2 in our #HyperK patient experience w/ myself, George Bakris, & Nieltje (@hdunews)

Supported by an educational grant from AstraZeneca Pharmaceuticals LP

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @hdunews Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC The #HyperK patient experience, part 2 is starting right now. Come join Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦, Nieltje (@hdunews), & I! Rajiv Agarwal MD, MS, Edgar V. Lerma 🇵🇭, ChristosArgyropoulos MD, PhD FlozinatorInChief

George Bakris Home Dialyzors News Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief Excited for another interesting #HyperK conversation! Use #HyperK to follow along & participate.

George Bakris Home Dialyzors News Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief ✅CME info 👉 bit.ly/3tqjnry
✅Faculty Affiliation & Disclosures 👇  
#HyperK

George Bakris Home Dialyzors News Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief Let’s kick things off with this poll: 📣Patients w/ ESRD, are you at risk of #HyperK ?
A.Yes, HK is fairly common for pts w/ ESRD
B.No, HK is uncommon for pts w/ ESRD
C.Unsure of rate of HK for pts w/ ESRD

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Home Dialyzors News Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief What is the prevalence and burden of #HyperK ?

🔹 HK occurs in ≤ 73% of pts w/ advanced CKD & ≤ 40% of pts w/ chronic HF
🔹 HK associated w/ ⬆️ hospitalizations & mortality
🔹 HK-related hospitalization & mortality ⬆️ when K+ testing & monitoring is not performed frequently

George Bakris Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief I tend to have super ⬇️ K+, which is just as much of a problem as ⬆️. & harder to diagnose on dialysis. B/c I have substantial RKF, I have no K+ burden & lost more during dialysis. Required a dialysate change. #HyperK @erichditschman @teknofiliac @miriamgodwin4

Home Dialyzors News George Bakris Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief ErichDitschman Wael Hussein Miriam Godwin 📣Patients with ESRD, do you know the severity of your #HyperK diagnosis?
A.Yes, I have mild HK
B.Yes, I have moderate HK
C.Yes, I had severe HK
D.No, I’m uncertain

Home Dialyzors News George Bakris Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief ErichDitschman Wael Hussein Miriam Godwin 🤔Why is knowing your #HyperK severity important❓

George Bakris Home Dialyzors News Gary Singer @[email protected] ChristosArgyropoulos MD, PhD FlozinatorInChief Swapnil Hiremath @[email protected]

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Home Dialyzors News Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief ErichDitschman Wael Hussein Miriam Godwin 🔹 Moderate-severe: need immediate tx & close monitoring to prevent arrhythmias & muscle paralysis
🔹 Severe: Independent predictor of all-cause & in-hospital mortality; mortality rate = ~30%, esp due to arrhythmias leading to cardiac arrest #HyperK

George Bakris Home Dialyzors News Swapnil Hiremath @[email protected] Gary Singer @[email protected] Matthew Sparks, MD KidneyColloquium Integrity CE Dr Anastasia Mihailidou FAHA FCSANZ FESC Rajiv Agarwal MD, MS Edgar V. Lerma 🇵🇭 ChristosArgyropoulos MD, PhD FlozinatorInChief ErichDitschman Wael Hussein Miriam Godwin 📣Patients with ESRD, how was your #HyperK discovered or confirmed?
A.🔎Discovered during a routine blood test
B.⌛️Confirmed as chronic over 1-yr period
C.⏱️Confirmed as acute during ER visit due to abnormal heart rhythm